Clinical Trials Directory

Trials / Completed

CompletedNCT00746226

Probiotics for Birch Pollen Allergy

Probiotic Intervention for Children With Birch Pollen Allergy

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Danisco · Industry
Sex
All
Age
2 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Birch pollen allergy is one of the most common forms of respiratory allergy in the Nordic countries. Treatment consists of antihistamine use. Specific probiotic strains have been observed to modulate the immune system. Since the body has a common mucosal immune system; it was hypothesised that consumption of probiotics may affect also the respiratory mucosal immune response and hence affect respiratory allergy. Earlier studies with probiotics had been unable to show improvements in adults with pollen allergy. It was therefore hypothesised that children, who's immune system is not yet fully developed, might be better targets.

Conditions

Interventions

TypeNameDescription
BIOLOGICALLactobacillus acidophilus and Bifidobacterium lactisDaily 5x10\^9 CFU of a combination of L. acidophilus and B. lactis
BIOLOGICALPlaceboMicrocrystalline cellulose As capsule which could be opened

Timeline

Start date
2006-03-01
Primary completion
2006-06-01
Completion
2007-02-01
First posted
2008-09-03
Last updated
2008-09-03

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00746226. Inclusion in this directory is not an endorsement.